Recently approved and emerging drug options for migraine prophylaxis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2102420
Abstract: ABSTRACT Introduction Migraine occupies the first position regarding the disability caused in female working population (15–49 years). Research in the field of prophylaxis in this pathology has made enormous strides in recent years. Areas covered… read more here.
Keywords: drug options; recently approved; migraine prophylaxis; approved emerging ... See more keywords